Με ιδιαίτερο επιστημονικό ενδιαφέρον ολοκληρώθηκε το 4ο Διεθνές Συμπόσιο «Heart Failure: From Prevention to Transplantation» στην Αρμενία (1–3 Οκτωβρίου 2026)
Ιδιαίτερη τιμή αποτέλεσε η βράβευσή μου από τους διοργανωτές, καθώς και η βράβευση του Προέδρου της EKE κ. Κ.Τουτούζα
Gerasimos Filippatos retweeted
Plenary Session 9 Live Now!
Don’t miss this important session focused on Non-Steroidal MRAs in Cardio-Renal-Metabolic Care at e-Space CRM 2025. Learn from global experts on how these treatments are shaping clinical practice in heart kidney and liver management.
Join us for a deep dive into:
- NS vs. Standard MRAs
- Evidence in 2025
- Initiating treatment in patients with poor kidney function
Join the conversation now! It’s free & virtual : espace-crm.org
#NonSteroidalMRAs #HeartFailure #CKD #T2D #eSPACECRM2025
INTERESTING SURVEY FOR HEALTH CARE PROFESSIONALS ABOUT THE GUIDELINES. Follow the link:
medsurveys.questionpro.com/t…
Gerasimos Filippatos retweeted
#Finerenone significantly ⬇️ the risk of all-cause and CV #mortality vs. placebo in patients with #T2D across a broad spectrum of #CKD stages 🫀
More at #ehjcvp academic.oup.com/ehjcvp/adva…
#CardioTwitter #EHJPharmacotherapy #Cardiology #kidney @AgewallStefan @Filippatos @JJheart_doc
Gerasimos Filippatos retweeted
A study from @MassEyeAndEar shows that approximately one quarter of Americans who had COVID-19 never fully recovered their sense of taste or smell, which has impacted their quality of life (via @NBC10Boston) nbcboston.com/news/local/ext…
Gerasimos Filippatos retweeted
Happy Father’s Day to all those fortunate enough to take on the role of being a dad or father-figure. To Malia and Sasha, being your dad will always be the greatest gift of my life.
Gerasimos Filippatos retweeted
13 cases in 6.30h (9 cryoablation, 2 PMs and 2 ILRs). Team work is the secret! @ipetemil @athsaplaouras @SteliosDragasis @MEfraimidis plus I. Patsiotis #onassiscardiacsurgerycenter
Gerasimos Filippatos retweeted
The case for UACR for cardiologists:
BP/lipids are modifiable CV risk factors is well known.
CKD is a CV risk factor, but is it modifiable?
ja.ma/3Pl0XDc
@P_Rossing @Filippatos @KatherineTuttl8 @mvaduganathan @ChristophWanne4 @sameerbansilal @gbakris
Gerasimos Filippatos retweeted
Absolutely agree. With great faculty and friendly environment…as always @GMCRosano @MarcoMetra @MariannaAdamo1 @cardioceptor @m_piepoli @GianluSava @ShelleyZieroth @JavedButler1 @JBauersachsMD @HillLoreena @EkateriniL @HanCardiomd @ARakisheva @Filippatos
Excellent meeting - Heart Failure International Forum (7th Edition)
Event endorsed by #HFA
@HFA_President @GianluSava @DragoG10 @SotiriaLiori @francmusella @ESC_Journals
Gerasimos Filippatos retweeted
Here is a new metric: number of pictures taken during a presentation Congratulations all for this inspiring, lively, highly participated HFA course on Advanced HF! @HFA_President @WilfriedMullens @MariannaAdamo1 @MRMehraMD @escardio
Gerasimos Filippatos retweeted
Finerenone reduces mortality in chronic kidney disease and type 2 diabetes while on treatment: a FIDELITY analysis academic.oup.com/ehjcvp/arti… @Stenodiabetes @Filippatos @AgarwalRajivMD @BakrisGeorge
Gerasimos Filippatos retweeted
Illusion of knowledge is more dangerous than ignorance:
It's Okay to say "I don't know" and admit that you don't know it.
It's shameful to pretend that you know everything.
Gerasimos Filippatos retweeted
You would like to learn the best novelties on rapid implementation of HF therapies? Come tomorrow at 8:30 am in Main Event II near the entrance at the right side. You will be the first to hear about STRONG-HF @univ_paris_cite @Inserm @HopLariboisiere
Gerasimos Filippatos retweeted
Further reading @ ahajournals.org/doi/10.1161/… (5/5)
@WilsonTangMD @EvelyneMeekers @petra_nijst
@JeroenDauw @kevin_damman @AlexMebazaa
@MarcoMetra @Filippatos @robmentz @jozinetm @Uhasselt @futurehealthzol @KCETrials
@HanCardiomd
Gerasimos Filippatos retweeted
Gerasimos Filippatos retweeted
UACR is a HF marker. Consistent benefits across eGFR & UACR categories with finerenone in HF-related outcomes in pts with CKD and T2D. Results from FIDELITY (Combined FIDELIO-DKD and FIGARO-DKD Analysis) @JACCJournals #JACCHF jacc.org/doi/10.1016/j.jchf.… @Filippatos @BakrisGeorge











































